OIP5 and metastatic malignant neoplasm in the lymph nodes: The results suggested that OIP5-AS1 expression was higher in OC patients who were in an advanced International Federation of Gynecology and Obstetrics (FIGO) stage (Fig. 1B), lymph node metastasis (LNM) (Fig. 1C) and larger tumor size (Fig. 1D).